0.083
0.08 (-124.30%)
As of Mar 06, 2023
Rubius Therapeutics, Inc. [RUBY]
Source:
Company Overview
Rubius Therapeutics, Inc is a biopharmaceutical company that has developed a platform and pipeline focused on creating an entirely new class of cellular medicines called Red Cell Therapeutics, or RCTs, for the treatment of cancer and autoimmune diseases.
| Country | United States |
| Headquarters | foxboro, massachusetts |
| Phone Number | 617-679-9600 |
| Industry | manufacturing |
| CEO | Dannielle Appelhans |
| Website | rubiustx.com |